AI assistant
Beta Bionics, Inc. — Director's Dealing 2025
Jan 30, 2025
32351_dirs_2025-01-29_076aa76b-1326-4c66-8956-fef80759af0f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-29
Reporting Person: Feider Stephen (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.51 | 2032-07-31 | Class B Common Stock (166542) | Direct | |
| Employee Stock Option (right to buy) | $5.10 | 2033-09-13 | Class B Common Stock (109695) | Direct |
Footnotes
F1: One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
F2: In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the initial public offering.
F3: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.